Join
Live feed
·
NEWSReleasevia Quantisnow
Merrimack Pharmaceuticals Inc. logo

Merrimack Secures $225M Milestone Payment From Ipsen; Says It Is Unlikely That Any Additional Milestone Payments Will Become Payable

ByQuantisnow·Wall Street's wire, on your screen.
MACK· Merrimack Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MACK (Merrimack Pharmaceuticals Inc.) and more on Quantisnow.